Diana Cirstea, MD

• Multiple Myeloma

I grew up and received my medical degree in the Republic of Moldova. My passion for multiple myeloma ignited when I joined Noopur Raje’s translational research lab. My work focused on novel anti-myeloma therapeutics including CDK inhibitors and agents targeting PI3K/Akt/mTOR pathway both alone and in combination with conventional therapies. Next, during my three-year Hematology/Oncology Fellowship at Boston Medical Center I had the privilege to care for patients originating from diverse socio-economic and ethnic backgrounds, presenting with advanced malignancies, rare and often severe hematological conditions. There I developed an interest in stem cell transplant that led to my first job as a BMT hospitalist at the Dana-Farber Cancer Institute/Brigham and Women’s Hospital, focusing on the inpatient care of patients receiving stem cell transplant and other forms of cell therapy including CAR-T. In August 2022 I joined the Mass General Cancer Center Multiple Myeloma Program, where I will be caring for patients with plasma cell disorders and conducting research, with a particular interest in cellular immunotherapy in myeloma.